ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

May 30, 2003

NCI, Dialogue Plan A National Tissue Bank

July 11, 2003

OMB Backs Down, May Release New Construction Funds For UCLA, Salk, NYU

April 25, 1975

ACS Asks Congress For $1.32 Billion NCI ’87 Budget

April 4, 1986

The Cancer Letter’s Paul Goldberg Wins Journalism Award

April 10, 2009

Cancer Programs Close Amid Gridlock

October 4, 2013